NCT04258501 is a NA clinical trial of Mulberry fruit in Blood Glucose, sponsored by Unilever R&D.

Who is sponsoring NCT04258501?

NCT04258501 is sponsored by Unilever R&D.

What drugs are being tested in NCT04258501?

Interventions in NCT04258501: Mulberry fruit, Mulberry leaf, White bean, Apple, Elderberry, Turmeric, Rice porridge.

What condition does NCT04258501 study?

NCT04258501 studies Blood Glucose.

Is NCT04258501 still recruiting?

NCT04258501 is currently completed. Last updated 6 February 2020.

Last reviewed 2020-02-06 · How we verify

NCT04258501

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response

Completed NA Last updated 6 February 2020

What this trial tests

NA trial testing Mulberry fruit in Blood Glucose in 72 participants. Completed in 6 January 2012.

Timeline

24 November 2011

Primary endpoint
6 January 2012

6 January 2012

Quick facts

Lead sponsor	Unilever R&D
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	basic science
Enrollment	72
Start date	24 November 2011
Primary completion	6 January 2012
Estimated completion	6 January 2012
Sites	1 location across India

Drugs / interventions tested

Mulberry fruit
Mulberry leaf
White bean
Apple
Elderberry
Turmeric — full drug profile →
Rice porridge

Conditions studied

Blood Glucose — all drugs for Blood Glucose →

Sponsor

Unilever R&D — full company profile →

Who can join

Adults 20 to 50, any sex, with Blood Glucose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized, balanced, incomplete block design exploratory study of efficacy, with 8 active treatments (4 treatments per subject; 35 or 37 subjects per treatment) compared to a reference treatment (all 72 subjects).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions.
Sivani BM, Azzeh M, Patnaik R, Pantea Stoian A, et al · · 2022 · cited 26× · PMID 35888763 · DOI 10.3390/metabo12070639
The effect of 8 plant extracts and combinations on post-prandial blood glucose and insulin responses in healthy adults: a randomized controlled trial.
Mela DJ, Cao XZ, Dobriyal R, Fowler MI, et al · · 2020 · cited 13× · PMID 32647531 · DOI 10.1186/s12986-020-00471-x

Verify or expand the search:

Other recruiting trials for Blood Glucose

Currently open trials in the same condition.

NCT07272993 — Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes · NA · active not recruiting
NCT07103083 — Postprandial Response to Fruit Juice · NA · recruiting
NCT06398340 — Identifying Wearable Biomarkers to Monitor Dietary Intake · NA · recruiting
NCT06568497 — Dairy and Vegan Cheese: Effect on Satiety and Blood Glucose · NA · recruiting

Other Unilever R&D trials

Trials by the same sponsor.

NCT06640244 — The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening · NA · completed
NCT06413810 — The Effects of a Food Ingredient on Self-reported Stress · NA · completed
NCT05013801 — A Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate Melasma · NA · completed
NCT04155658 — Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation · NA · completed
NCT03953391 — The Effect of Tea Breaks on Cerebrovascular Perfusion During Desk Work · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04258501 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Unilever R&D
Last refreshed: 6 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04258501.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing